The glycoglycerolipid 1,2-dipalmitoyl-3-(N-palmitoyl-6′-amino-6′-deoxy-α-d-glucosyl)-sn-glycerol is no inhibitor of the human Myt1 kinase

A Fluorescence Anisotropy–Based Myt1 Kinase Binding Assay

(2013) Alexander Rohe et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Synthesis of 6′-acylamido-6′-deoxy-α-d-galactoglycerolipids

(2013) Chunxia Li et al.   CARBOHYDRATE RESEARCH

RNAi screening of the kinome with cytarabine in leukemias

(2012) R. Tibes et al.   BLOOD

Synthesis of glycoglycerolipid of 1,2-dipalmitoyl-3-(N-palmitoyl-6′-amino-6′-deoxy-α-d-glucosyl)-sn-glycerol and its analogues, inhibitors of human Myt1-kinase

(2012) Yihua Sun et al.   CARBOHYDRATE RESEARCH

Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay

(2012) Alexander Rohe et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery

(2012) J P H Chow et al.   ONCOGENE

In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase

(2011) Alexander Rohe et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Comprehensive analysis of kinase inhibitor selectivity

(2011) Mindy I Davis et al.   NATURE BIOTECHNOLOGY

Fluorescence polarization binding assay to develop inhibitors of inactive p38α mitogen-activated protein kinase

(2010) Lenka Munoz et al.   ANALYTICAL BIOCHEMISTRY

ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for Kinases

(2010) Hicham Zegzouti et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Fluorescence Polarization/Anisotropy in Diagnostics and Imaging

(2010) David M. Jameson et al.   CHEMICAL REVIEWS

First total synthesis of 1,2-dipalmitoyl-3-( N -palmitoyl-6′-amino-6′-deoxy-α- d -glucosyl)- sn -glycerol—a glycoglycerolipid of a marine alga with a high inhibitor activity against human Myt1-kinase

(2009) Christiane Göllner et al.   CARBOHYDRATE RESEARCH

Synthesis of Naturalα-6-Dehydroxy-6-aminoglucoglycerolipids

(2008) Hai-Jun WU et al.   CHINESE JOURNAL OF CHEMISTRY

Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib

(2008) Oliver Hantschel et al.   LEUKEMIA & LYMPHOMA